MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ouadid, H.
Right arrow Articles by Nargeot, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ouadid, H.
Right arrow Articles by Nargeot, J.

Serotonin increases calcium current in human atrial myocytes via the newly described 5-hydroxytryptamine4 receptors

H Ouadid, J Seguin, A Dumuis, J Bockaert and J Nargeot

CRBM, CNRS UPR 8402/INSERM U 249, Montpellier, France.

In various species, including humans, 5-hydroxytryptamine (5-HT) has been shown to exert positive chronotropic and inotropic cardiac effects through different types of receptors. The goal of the present study was to investigate the regulation by 5-HT of voltage-gated Ca2+ channels in human atrial myocytes and to characterize the receptor involved. Cardiomyocytes isolated enzymatically and mechanically were voltage- clamped using the whole-cell configuration of the patch-clamp technique. Extracellular perfusion of 5-HT increased Ca2+ current (ICa) amplitude with a EC50 (0.1 microM) similar to that observed with isoprenaline. The effects of 5-HT were blocked by the addition of protein kinase A inhibitor in the pipette. In addition, the effects of 5-HT, isoprenaline, and intracellular cAMP on ICa were not additive. These results support the hypothesis that the inotropic effect of 5-HT in human atrial myocytes is related to an increase of ICa via an elevation of intracellular cAMP levels and stimulation of cAMP- dependent protein kinase. The effects of 5-HT were not blocked by antagonists of 5-HT1 (methiothepin), 5-HT2 (ketanserin), or 5-HT3 (ICS 205-930 at a low concentration) receptors. The benzamide derivatives renzapride and zacopride and the azabicyclobenzimidazolone derivative BIMU 8 increased ICa, but less efficiently than did 5-HT or 5- methoxytryptamine. Moreover, ICS 205-930 at high concentrations (greater than 1 microM) completely antagonized the effects of 5-HT. Thus, the pharmacology of the 5-HT receptor involved in an increase of ICa in human atrial myocytes resembles that recently described for the 5-HT4 receptor. In atrial myocytes dissociated from rat, rabbit, guinea pig, or frog, 5-HT at high concentrations had no effect on Ca2+ currents, suggesting that the distribution of 5-HT4 receptors in cardiac tissues is species dependent.

Volume 41, Issue 2, pp. 346-351, 02/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. A. K. Birkeland, F. Swift, N. Tovsrud, U. Enger, P. K. Lunde, E. Qvigstad, F. O. Levy, O. M. Sejersted, and I. Sjaastad
Serotonin increases L-type Ca2+ current and SR Ca2+ content through 5-HT4 receptors in failing rat ventricular cardiomyocytes
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2367 - H2376.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Liu, M. S. Geddis, Y. Wen, W. Setlik, and M. D. Gershon
Expression and function of 5-HT4 receptors in the mouse enteric nervous system
Am J Physiol Gastrointest Liver Physiol, December 1, 2005; 289(6): G1148 - G1163.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Qu, G. Baroudi, Y. Yue, N. El-Sherif, and M. Boutjdir
Localization and modulation of {alpha}1D (Cav1.3) L-type Ca channel by protein kinase A
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2123 - H2130.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Pau, A. J. Workman, K. A. Kane, and A. C. Rankin
Electrophysiological Effects of Prucalopride, a Novel Enterokinetic Agent, on Isolated Atrial Myocytes from Patients Treated with {beta}-Adrenoceptor Antagonists
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 146 - 153.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Cao, J. H. Han, S. Z. Kim, K. W. Cho, and S. H. Kim
Diverse regulation of atrial natriuretic peptide secretion by serotonin receptor subtypes
Cardiovasc Res, August 1, 2003; 59(2): 360 - 368.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. Yusuf and A. J. Camm
Sinus Tachyarrhythmias and the Specific Bradycardic Agents: A Marriage Made in Heaven?
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2003; 8(2): 89 - 105.
[Abstract] [PDF]


Home page
Mol. Pharmacol.Home page
A. Pindon, G. van Hecke, P. van Gompel, A. S. Lesage, J. E. Leysen, and M. Jurzak
Differences in Signal Transduction of Two 5-HT4 Receptor Splice Variants: Compound Specificity and Dual Coupling with Galpha s- and Galpha i/o-Proteins
Mol. Pharmacol., January 1, 2002; 61(1): 85 - 96.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Boixel, S. Dinanian, L. Lang-Lazdunski, J.-J. Mercadier, and S. N. Hatem
Characterization of effects of endothelin-1 on the L-type Ca2+ current in human atrial myocytes
Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H764 - H773.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Barrere-Lemaire, C. Piot, F. Leclercq, J. Nargeot, and S. Richard
Facilitation of L-type calcium currents by diastolic depolarization in cardiac cells: impairment in heart failure
Cardiovasc Res, August 1, 2000; 47(2): 336 - 349.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Boixel, S. Tessier, Y. Pansard, L. Lang-Lazdunski, J.-J. Mercadier, and S. N. Hatem
Tyrosine kinase and protein kinase C regulate L-type Ca2+ current cooperatively in human atrial myocytes
Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H670 - H676.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. M. Rahme, B. Cotter, E. Leistad, M. K. Wadhwa, R. Mohabir, A. P. D. W. Ford, R. M. Eglen, and G. K. Feld
Electrophysiological and Antiarrhythmic Effects of the Atrial Selective 5-HT4 Receptor Antagonist RS-100302 in Experimental Atrial Flutter and Fibrillation
Circulation, November 9, 1999; 100(19): 2010 - 2017.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Pino, E. Cerbai, G. Calamai, F. Alajmo, A. Borgioli, L. Braconi, M. Cassai, G. F. Montesi, and A. Mugelli
Effect of 5-HT4 receptor stimulation on the pacemaker current If in human isolated atrial myocytes
Cardiovasc Res, December 1, 1998; 40(3): 516 - 522.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Sanders, J. A. Lynham, B. Bond, F. del Monte, S. E. Harding, and A. J. Kaumann
Sensitization of Human Atrial 5-HT4 Receptors by Chronic ß-Blocker Treatment
Circulation, November 1, 1995; 92(9): 2526 - 2539.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
C. Boixel, W. Gonzalez, L. Louedec, and S. N. Hatem
Mechanisms of L-Type Ca2+ Current Downregulation in Rat Atrial Myocytes During Heart Failure
Circ. Res., September 28, 2001; 89(7): 607 - 613.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics